by Kathy Jones on  September 21, 2012 at 9:52 PM Corporate News
 Dr Reddy’s Starts Marketing Amoxicillin Tablets in US
Hyderabad-based pharmaceutical company Dr Reddy's Laboratories announced that it has started marketing amoxicillin tablets, capsules and oral suspension, a bioequivalent generic version of Amoxil (amoxicillin) tablets, capsules and oral suspension in the US market.

The company said that it has received approval from the US Food and Drug Administration to market the drugs and revealed that the amoxicillin tablets will be available in 500 mg and 875 mg strengths, capsules in 250 mg and 500 mg strengths while the oral suspension will be available in 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, and 400 mg/5 ml strengths.



Source: Medindia

Most Popular on Medindia

More News on: